These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 23850262

  • 1. Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.
    Jenkins AJ, Yu J, Alaupovic P, Basu A, Klein RL, Lopes-Virella M, Baker NL, Hunt KJ, Lackland DT, Garvey WT, Lyons TJ, DCCT/EDIC Research Group.
    J Diabetes Complications; 2013; 27(5):447-53. PubMed ID: 23850262
    [Abstract] [Full Text] [Related]

  • 2. Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
    Basu A, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Schade DS, Wood J, Alaupovic P, Lyons TJ, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.
    J Lipid Res; 2018 May; 59(5):872-883. PubMed ID: 29576550
    [Abstract] [Full Text] [Related]

  • 3. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL, DCCT/EDIC Research Group.
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    Metabolism; 2004 Oct; 53(10):1296-304. PubMed ID: 15375785
    [Abstract] [Full Text] [Related]

  • 5. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia.
    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL, DCC/EDIC Research Group.
    Diabetes Care; 2003 Mar; 26(3):810-8. PubMed ID: 12610042
    [Abstract] [Full Text] [Related]

  • 6. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
    Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group.
    Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
    [Abstract] [Full Text] [Related]

  • 7. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort.
    Lyons TJ, Jenkins AJ, Zheng D, Lackland DT, McGee D, Garvey WT, Klein RL.
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):910-8. PubMed ID: 14985310
    [Abstract] [Full Text] [Related]

  • 8. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
    Siegel RD, Cupples A, Schaefer EJ, Wilson PW.
    Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
    [Abstract] [Full Text] [Related]

  • 9. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes.
    Chaturvedi N, Fuller JH, Taskinen MR, EURODIAB PCS Group.
    Diabetes Care; 2001 Dec; 24(12):2071-7. PubMed ID: 11723085
    [Abstract] [Full Text] [Related]

  • 10. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M.
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [Abstract] [Full Text] [Related]

  • 11. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O, Attman PO, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P.
    Nephron; 1997 May; 75(3):286-94. PubMed ID: 9069450
    [Abstract] [Full Text] [Related]

  • 12. Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.
    Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.
    Diabetes Care; 1996 Dec; 19(12):1382-7. PubMed ID: 8941468
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.
    Aroner SA, Furtado JD, Sacks FM, Tsai MY, Mukamal KJ, McClelland RL, Jensen MK.
    Diabetologia; 2019 Jun; 62(6):981-992. PubMed ID: 30949716
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial.
    Azar M, Lyons TJ, Alaupovic P, Stoner JA, Quiroga C, Kaufman DG, Lopes-Virella M, Klein RL, Jenkins AJ, VADT Study Group.
    J Diabetes Complications; 2013 Jun; 27(6):627-32. PubMed ID: 23911536
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    J Diabetes Complications; 2005 Jun; 19(1):18-25. PubMed ID: 15642486
    [Abstract] [Full Text] [Related]

  • 16. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D.
    Basu A, Bebu I, Jenkins AJ, Stoner JA, Zhang Y, Klein RL, Lopes-Virella MF, Garvey WT, Budoff MJ, Alaupovic P, Lyons TJ, Diabetes Control Complications Trial/Epidemiology of Diabetes Interventions Complications Research Group.
    J Lipid Res; 2019 Aug; 60(8):1432-1439. PubMed ID: 31203233
    [Abstract] [Full Text] [Related]

  • 17. Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria.
    Kapelrud H, Bangstad HJ, Dahl-Jørgensen K, Berg K, Hanssen KF.
    BMJ; 1991 Sep 21; 303(6804):675-8. PubMed ID: 1833011
    [Abstract] [Full Text] [Related]

  • 18. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO, Alaupovic P, Tavella M, Knight-Gibson C.
    Nephrol Dial Transplant; 1996 Jan 21; 11(1):63-9. PubMed ID: 8649654
    [Abstract] [Full Text] [Related]

  • 19. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P, Humphries SE.
    Clin Genet; 1994 Oct 21; 46(4):273-82. PubMed ID: 7834891
    [Abstract] [Full Text] [Related]

  • 20. Lipid abnormalities in insulin-dependent diabetic patients with albuminuria.
    Vannini P, Ciavarella A, Flammini M, Bargossi AM, Forlani G, Borgnino LC, Orsoni G.
    Diabetes Care; 1984 Oct 21; 7(2):151-4. PubMed ID: 6734382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.